ArticlePediatric endocrinology, diabetes, and metabolism2025
Complications of obesity in children and youths with type 1 diabetes mellitus.
Article in Pediatric endocrinology, diabetes, and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Bidirectional Relationship Between Type 1 Diabetes Mellitus and Obesity in Pediatric Patients: A Systematic Review.Children (Basel, Switzerland) · 2026Review
- A commentary on "High prevalence of metabolic comorbidities in Asian children with type 1 diabetes and obesity".Annals of pediatric endocrinology & metabolism · 2026Article
- Unlocking the heterogeneity of pediatric obesity: a phenotypic subtype-based paradigm for precision management.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionExcess body weight has a negative impact on the management of type 1 diabetes (T1D) and is an additional risk factor for the development of chronic vascular complications, insulin resistance and metabolic dysfunction-associated fatty liver disease (MAFLD). We compared and analyzed metabolic control, the incidence of insulin resistance and MAFLD in children and youths with T1D and excessive body weight (T1D-E) and those with T1D and normal body weight (T1D-N). MATERIAL AND
methodsThe study included 32 patients with T1D-N and 31 patients with T1D-E. Daily insulin requirement, estimated glucose disposal rate (eGDR1, eGDR2), HbA1C%, lipid profile, vitamin D level, cIMT value, and MAFLD prevalence were compared in relation to body mass index (BMI) and BMI SD score (BMI-SDS).
resultsT1D-E patients compared to T1D-N had higher systolic (125.58 ±8.18 vs. 120.16 ±10.02 mmHg, p = 0.022) and diastolic blood pressure (78.19 ±7.03 vs. 73.94 ±7.95 mmHg, p = 0.028), triglyceride levels (118.19 ±71.20 vs. 71.31 ±18.76 mg/dl, p = 0.001) and waist circumference (p < 0.001). Lower eGDR values were noted in T1D-E vs. T1D-N: eGDR1: 5.16 ±1.33 vs. 6.96 ±1.32; eGDR2: 9.37 ±1.21 vs. 10.66 ±0.9 (p = 0.0001, p = 0.0001). Vitamin D levels were lower and the incidence of MAFLD was higher in the T1D-E group (13% vs. 0%, p = 0.014). Patients with MAFLD had worse lipid profile results and higher cIMT values (0.48 vs. 0.43 mm, p = 0.4).
conclusionsExcessive body weight in patients with T1D leads to elevated blood pressure, dyslipidemia, and insulin resistance, and increases the risk of MAFLD. Patients with MAFLD have a higher future cardiovascular risk, expressed as an increased cIMT value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.